Atlas Trials

12-Week Efficacy And Safety Of Pregabalin In Treating Restless Legs Syndrome (RLS) Subjects

Clinical trial NCT01061372 · WITHDRAWN

Trial details

NCT number
NCT01061372
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Restless Legs Syndrome
Start date
2010-05-01
Primary completion
2011-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.